Analysts anticipate Gilead Sciences to report an earnings per share (EPS) of $1.55.
Gilead Sciences bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.41, leading to a 2.55% drop in the share price on the subsequent day.
Here's a look at Gilead Sciences's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
1.60
-1.49
1.78
1.92
EPS Actual
2.01
-1.32
1.72
2.29
Price Change %
-3.0%
0.0%
-4.0%
-3.0%
Performance of Gilead Sciences Shares
Shares of Gilead Sciences were trading at $89.84 as of November 04. Over the last 52-week period, shares are up 15.33%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Views on Gilead Sciences
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Gilead Sciences.
The consensus rating for Gilead Sciences is Neutral, based on 16 analyst ratings. With an ...
